Genentech boosts U.S. presence with new $700 million North Carolina facility
On May 12, 2025, Genentech announced plans to invest more than $700 million in a new 700,000 square…
Mandatory masking in schools reduced COVID-19 cases during Delta surge
On Mar. 10, 2022, schools with mandatory masking during the Delta surge had approximately 72% fewer cases of…
Biotechnology | CDC | Infectious Disease | Influenza | NIH | Therapeutics
U.S. Government exercised option to purchase additional RAPIVAB from BioCryst for delivery to Strategic National Stockpile
On Sept. 3, 2020, BioCryst Pharmaceuticals announced that the U.S. Department of Health and Human Services (HHS) had…
Disease | NIH | Therapeutics
NIAID awarded BioCryst $44 million contract to advance development of galidesivir
On Aug. 31, 2020, BioCryst Pharmaceuticals announced that the National Institute of Allergy and Infectious Diseases (NIAID) had…
Novavax and UK Government announced collaboration and purchase agreement for Novavax’ COVID-19 vaccine candidate
On Aug. 14, 2020, Novavax announced it had signed a Heads of Terms (Term Sheet) with the Government…
NIH-Moderna investigational COVID-19 vaccine showed promise in mouse studies
On Aug. 5, 2020, the National Institute of Allergy and Infectious Diseases (NIAID) announced that the investigational vaccine…
BioCryst’s galidesivir stops Zika viral replication in primate model
On Jun. 11, 2020, BioCryst Pharmaceuticals announced new data published in Science Translational Medicine that show, in a…
Albert Einstein College of Medicine invented compound tested in COVID-19 clinical trial
On Apr. 29, 2020, researchers at Montefiore Health System and Albert Einstein College of Medicine announced that a…
BioCryst began clinical trial with Galidesivir for treatment of patients with COVID-19
On Apr. 9, 2020, BioCryst Pharmaceuticals announced the company has opened enrollment into a randomized, double-blind, placebo-controlled clinical…
Seqirus’ Next Generation Cell-based Influenza Vaccine Shows Significantly Greater Effectiveness Compared to Standard Egg-based Options in the 2017-18 US Influenza Season
On Dec. 5, 2018, Seqirus, a CSL subsidiary, announced real-world data showing that its cell-based quadrivalent influenza vaccine…
Biotechnology | CDC | NIH | Non-Profit Research | Pharmaceutical | Therapeutics | Vaccine
CDC published ACIP recommendations for use of herpes zoster vaccines
On Jan. 26, 2018, the U.S. Centers for Disease Control and Prevention’ (CDC) Immunization Practices Advisory Committee (ACIP)…
Norman “Ned” Sharpless was sworn in as the 15th Director of the National Cancer Institute
On Oct. 17, 2017, Norman “Ned” Sharpless was sworn in as the 15th Director of the National Cancer…
Seqirus announced major advances in pandemic preparedness
On Aug. 7, 2017, Seqirus announced that the accelerated development of cell-based manufacturing technology at its state-of-the-art manufacturing…
SpringWorks Therapeutics was founded
In 2017, SpringWorks Therapeutics was founded in Stamford, Connecticut, as a clinical-stage biopharmaceutical company that applies a precision…
Patheon completed it IPO
On Jul. 26, 2016, Patheon announced the closing of its initial public offering of 34,226,191 of its ordinary…
FDA approved Hiberix for full Hib vaccineﾠ series
On Apr. 29, 2016, GlaxoSmithKline Biologicals in Research Triangle Park, North Carolina, received U.S. Food and Drug Administration…
The Tardigrade Genome was Sequenced, world first
On Nov. 25, 2015, scientists from the University of North Carolina at Chapel Hill announced they had sequenced…
Nobel Prize in Chemistry for 2015 awarded to Tomas Lindahl, Paul Modrich and Aziz Sancar
On Oct. 7, 2015, the Nobel Prize in Chemistry for 2015 was awarded to Tomas Lindahl, Francis Crick…
RTP announced plans for a $50 million redevelopment
On Oct. 1, 2015 the President and CEO of the Research Triangle Foundation (RTP), Bob Geolas, announced RTP’s…
BioCryst’s RAPIVAB(TM) (peramivir injection) received FDA approval for treatment of influenza in adults
On Dec. 22, 2014, BioCryst Pharmaceuticals announced the U.S. Food and Drug Administration (FDA) had approved RAPIVAB (peramivir…
The North Carolina Eshelman School of Pharmacy received $100 million donation from Fred Eshelman
On Dec. 3, 2014, Fred Eshelman, CEO and founder of Wilmington-based PPD Inc. and a member of the…
David H Murdock announced endowment for DHMRI
On Sept. 30, 2014, David H. Murdock, owner and chair of Castle & Cooke, and builder and founder…
Grifols opened state-of-the-art facility in Clayton to advance treatment of rare and life-threatening diseases
On Jun. 17, 2014, Grifols opened state-of-the-art North Fractionation Facility (NFF) in Clayton, NC, where production capacity of…
Myron Cohen received the North Carolina Award for Science
On Oct. 22, 2013 Myron Cohen received the North Carolina Award for Science. Dr. Cohen is a University…
Duke Cancer Institute opened the Duke Cancer Center, a new 7-floor building
On Feb. 27, 2012, the Duke Cancer Institute opened a new 267,000-square-foot, $235 million Cancer Center that included…
The Belly Button Biodiversity project was launched
On Jan. 3, 2011, the Belly Button Biodiversity project was launched to investigate the microbes inhabiting our navels…
HHS awarded a $487 million contract to Novartis to build a facility to manufacture cell-based influenza vaccine
On Jan. 15, 2009, the U.S. Dept. of Health and Human Services (HHS) awarded Novartis a $487 million…
The North Carolina School of Pharmacy was renamed in honor of Fred Eshelman
On May 21, 2008, the North Carolina School of Pharmacy was renamed the Eshelman School of Pharmacy in…
Oliver Smithies was awarded the 2007 Nobel Prize in Physiology or Medicine
On Oct. 8, 2007, the Nobel Prize in Physiology or Medicine was awarded jointly to Oliver Smithies from…
David H Murdock donated $35 million to Duke University to fund the Measurement to Understand the Reclassification of Disease
On Sept. 24, 2007, David H. Murdock donated $35 million to Duke University to fund the Measurement to…